Citations to this article
Abstract
Convalescent plasma with severe acute respiratory disease coronavirus 2 (SARS-CoV-2) antibodies (CCP) may hold promise as a treatment for coronavirus disease 2019 (COVID-19). We compared the mortality and clinical outcome of patients with COVID-19 who received 200 mL of CCP with a spike protein IgG titer ≥ 1:2430 (median 1:47,385) within 72 hours of admission with propensity score–matched controls cared for at a medical center in the Bronx, between April 13 and May 4, 2020. Matching criteria for controls were age, sex, body mass index, race, ethnicity, comorbidities, week of admission, oxygen requirement, D-dimer, lymphocyte counts, corticosteroid use, and anticoagulation use. There was no difference in mortality or oxygenation between CCP recipients and controls at day 28. When stratified by age, compared with matched controls, CCP recipients less than 65 years had 4-fold lower risk of mortality and 4-fold lower risk of deterioration in oxygenation or mortality at day 28. For CCP recipients, pretransfusion spike protein IgG, IgM, and IgA titers were associated with mortality at day 28 in univariate analyses. No adverse effects of CCP were observed. Our results suggest CCP may be beneficial for hospitalized patients less than 65 years, but data from controlled trials are needed to validate this finding and establish the effect of aging on CCP efficacy.
Authors
Hyun ah Yoon, Rachel Bartash, Inessa Gendlina, Johanna Rivera, Antonio Nakouzi, Robert H. Bortz III, Ariel S. Wirchnianski, Monika Paroder, Karen Fehn, Leana Serrano-Rahman, Rachelle Babb, Uzma N. Sarwar, Denise Haslwanter, Ethan Laudermilch, Catalina Florez, M. Eugenia Dieterle, Rohit K. Jangra, J. Maximilian Fels, Karen Tong, Margarette C. Mariano, Olivia Vergnolle, George I. Georgiev, Natalia G. Herrera, Ryan J. Malonis, Jose A. Quiroz, Nicholas C. Morano, Gregory J. Krause, Joseph M. Sweeney, Kelsie Cowman, Stephanie Allen, Jayabhargav Annam, Ariella Applebaum, Daniel Barboto, Ahmed Khokhar, Brianna J. Lally, Audrey Lee, Max Lee, Avinash Malaviya, Reise Sample, Xiuyi A. Yang, Yang Li, Rafael Ruiz, Raja Thota, Jason Barnhill, Doctor Y. Goldstein, Joan Uehlinger, Scott J. Garforth, Steven C. Almo, Jonathan R. Lai, Morayma Reyes Gil, Amy S. Fox, Kartik Chandran, Tao Wang, Johanna P. Daily, Liise-anne Pirofski
Citation information
Citations to this article (34)
| Title and authors | Publication | Year |
|---|---|---|
|
SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients
Celikgil A, Massimi AB, Nakouzi A, Herrera NG, Morano NC, Lee JH, Yoon HA, Garforth SJ, Almo SC |
PloS one | 2023 |
|
Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis
Senefeld JW, Gorman EK, Johnson PW, Moir ME, Klassen SA, Carter RE, Paneth NS, Sullivan DJ, Morkeberg OH, Wright RS, Fairweather D, Bruno KA, Shoham S, Bloch EM, Focosi D, Henderson JP, Juskewitch JE, Pirofski LA, Grossman BJ, Tobian AA, Franchini M, Ganesh R, Hurt RT, Kay NE, Parikh SA, Baker SE, Buchholtz ZA, Buras MR, Clayburn AJ, Dennis JJ, Diaz Soto JC, Herasevich V, Klompas AM, Kunze KL, Larson KF, Mills JR, Regimbal RJ, Ripoll JG, Sexton MA, Shepherd JR, Stubbs JR, Theel ES, van Buskirk CM, van Helmond N, Vogt MN, Whelan ER, Wiggins CC, Winters JL, Casadevall A, Joyner MJ |
2023 | |
|
Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes
G Lasso, S Khan, S Allen, M Mariano, C Florez, E Orner, J Quiroz, G Quevedo, A Massimi, A Hegde, A Wirchnianski, R Bortz, R Malonis, G Georgiev, K Tong, N Herrera, N Morano, S Garforth, A Malaviya, A Khokhar, E Laudermilch, M Dieterle, J Fels, D Haslwanter, R Jangra, J Barnhill, S Almo, K Chandran, J Lai, L Kelly, J Daily, O Vergnolle, A Smith |
PLoS computational biology | 2022 |
|
Multi-center matched cohort study of convalescent plasma for hospitalized patients with COVID-19
Cindy Ke Zhou, Monica M Bennett, Carlos H Villa, Kendall Hammonds, Yun Lu, Jason Ettlinger, Elisa Priest, Robert Gottlieb, Steven Davis, Edward Mays, Tainya C Clarke, Azadeh Shoaibi, Hui-Lee Wong, Steven A Anderson, Ronan Kelly |
PloS one | 2022 |
|
Clinical trial sub-class analyses to investigate clinical and immunological outcomes of convalescent plasma therapy in severe COVID-19
Deblina Raychaudhuri, Purbita Bandopadhyay, Ranit D'Rozario, Jafar Sarif, Yogiraj Ray, Shekhar Ranjan Paul, Praveen Singh, Kausik Chaudhuri, Ritwik Bhaduri, Rajesh Pandey, Prasun Bhattacharya, Shantanu Sengupta, Shilpak Chatterjee, Dipyaman Ganguly |
Mayo Clinic Proceedings: Innovations, Quality & Outcomes | 2022 |
|
Efficacy and safety of convalescent plasma therapy in patients with moderate-to-severe COVID-19: A non-randomized comparative study with historical control in a referral hospital in Indonesia
J Kurnianda, MS Hardianti, T Triyono, JA Thobari, I Trisnawati, CF Wisudarti, U Sukorini, F Anshori, SA Setiawan, M Ucche, A Farahnaz, Y Suryani |
Journal of Infection and Public Health | 2022 |
|
Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients
M Beraud, E Meyer, M Lozano, A Bah, R Vassallo, B Brown |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2022 |
|
Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19
S Yang, Y Tong, L Chen, W Yu |
2022 | |
|
Expert consensus on the diagnosis and treatment of severe and critical coronavirus disease 2019 (COVID-19)
Shang Y, Wu J, Liu J, Long Y, Xie J, Zhang D, Hu B, Zong Y, Liao X, Shang X, Ding R, Kang K, Liu J, Pan A, Xu Y, Wang C, Xu Q, Zhang X, Zhang J, Liu L, Zhang J, Yang Y, Yu K, Guan X, Chen D |
2022 | |
|
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Focosi D, Franchini M, Pirofski LA, Burnouf T, Paneth N, Joyner MJ, Casadevall A |
Clinical microbiology reviews | 2022 |
|
Therapeutic plasma exchange: A potential therapeutic modality for critically ill adults with severe acute respiratory syndrome coronavirus 2 infection
Al\u2010Hashami S, Khamis F, Al\u2010Yahyay M, Al\u2010Dowaiki S, Al\u2010Mashaykhi L, Al\u2010Khalili H, Chandwani J, Al\u2010Salmi I, Al\u2010Zakwani I |
Journal of Clinical Apheresis | 2022 |
|
Characterization of pathogen‐inactivated COVID‐19 convalescent plasma and responses in transfused patients
Weisser M, Khanna N, Hedstueck A, Sutter ST, Roesch S, Stehle G, Sava M, Deigendesch N, Battegay M, Infanti L, Holbro A, Bassetti S, Pargger H, Hirsch HH, Leuzinger K, Kaiser L, Vu D, Baur K, Massaro N, Busch MP, Simmons G, Stone M, Felgner PL, de Assis RR, Khan S, Tsai C, Robinson PV, Seftel D, Irsch J, Bagri A, Buser AS, Corash L |
Transfusion | 2022 |
|
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy
Herman JD, Wang C, Burke JS, Zur Y, Compere H, Kang J, Macvicar R, Taylor S, Shin S, Frank I, Siegel D, Tebas P, Choi GH, Shaw PA, Yoon H, Pirofski LA, Julg BD, Bar KJ, Lauffenburger D, Alter G |
Cell reports. Medicine | 2022 |
|
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study
Cognasse F, Hamzeh-Cognasse H, Rosa M, Corseaux D, Bonneaudeau B, Pierre C, Huet J, Arthaud CA, Eyraud MA, Prier A, Duchez AC, Ebermeyer T, Heestermans M, Audoux-Caire E, Philippot Q, Le Voyer T, Hequet O, Fillet AM, Chavarin P, Legrand D, Richard P, Pirenne F, Gallian P, Casanova JL, Susen S, Morel P, Lacombe K, Bastard P, Tiberghien P |
EBioMedicine | 2022 |
|
Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19
Shanna A. Arnold Egloff, Angela Junglen, Joseph S Restivo, Marjorie Wongskhaluang, Casey Martin, Pratik Doshi, Daniel Schlauch, Gregg Fromell, Lindsay Sears, Mick Correll, Howard Burris, Charles LeMaistre |
Journal of Clinical Investigation | 2021 |
|
Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response
JD Herman, C Wang, C Loos, H Yoon, J Rivera, ME Dieterle, D Haslwanter, RK Jangra, RH Bortz, KJ Bar, B Julg, K Chandran, D Lauffenburger, L Pirofski, G Alter |
Nature Communications | 2021 |
|
Effect of time and titer in convalescent plasma therapy for COVID-19
P de Candia, F Prattichizzo, S Garavelli, RL Grotta, AD Rosa, A Pontarelli, R Parrella, A Ceriello, G Matarese |
iScience | 2021 |
|
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
SA Klassen, JW Senefeld, KA Senese, PW Johnson, CC Wiggins, SE Baker, N van Helmond, KA Bruno, L Pirofski, S Shoham, BJ Grossman, JP Henderson, RS Wright, DL Fairweather, NS Paneth, RE Carter, A Casadevall, MJ Joyner |
Frontiers in Medicine | 2021 |
|
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis
SA Klassen, JW Senefeld, PW Johnson, RE Carter, CC Wiggins, S Shoham, BJ Grossman, JP Henderson, J Musser, E Salazar, WR Hartman, NM Bouvier, ST Liu, L Pirofski, SE Baker, N van Helmond, RS Wright, DL Fairweather, KA Bruno, Z Wang, NS Paneth, A Casadevall, MJ Joyner |
Mayo Clinic Proceedings | 2021 |
|
Mortality Benefit of Convalescent Plasma in COVID-19: A Systematic Review and Meta-Analysis
V Bansal, KS Mahapure, I Mehra, A Bhurwal, A Tekin, R Singh, I Gupta, SS Rathore, H Khan, S Deshpande, S Gulati, P Armaly, M Sheraton, R Kashyap |
Frontiers in Medicine | 2021 |
|
Passive Immunity Should and Will Work for COVID-19 for Some Patients:
N Cimolai |
2021 | |
|
The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
A Casadevall, L Pirofski, MJ Joyner, DA Garsin |
mBio | 2021 |
|
The Effectiveness of Convalescent Plasma for the Treatment of Novel Corona Virus Disease 2019: A Systematic Review and Meta-Analysis
H Cao, L Ming, L Chen, X Zhu, Y Shi |
Frontiers in Medicine | 2021 |
|
Efficacy and Safety of Convalescent Plasma for COVID-19: A Systematic Review and Meta-analysis
M Prasad, T Seth, A Elavarasi |
Indian Journal of Hematology and Blood Transfusion | 2021 |
|
COVID‐19 convalescent plasma therapy: hit fast, hit hard!
D Focosi, M Franchini |
Vox Sanguinis | 2021 |
|
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
KL Kunze, PW Johnson, N van Helmond, JW Senefeld, MM Petersen, SA Klassen, CC Wiggins, AM Klompas, KA Bruno, JR Mills, ES Theel, MR Buras, MA Golafshar, MA Sexton, JC Soto, SE Baker, JR Shepherd, NC Verdun, P Marks, NS Paneth, DL Fairweather, RS Wright, CM van Buskirk, JL Winters, JR Stubbs, KA Senese, MC Pletsch, ZA Buchholtz, RF Rea, V Herasevich, ER Whelan, AJ Clayburn, KF Larson, JG Ripoll, KJ Andersen, ER Lesser, MN Vogt, JJ Dennis, RJ Regimbal, PR Bauer, JE Blair, A Casadevall, RE Carter, MJ Joyner |
Nature Communications | 2021 |
|
Convalescent plasma for COVID-19: a meta-analysis, trial sequential analysis, and meta-regression
TA Snow, N Saleem, G Ambler, E Nastouli, LE McCoy, M Singer, N Arulkumaran |
British Journal of Anaesthesia | 2021 |
|
CONVALESCENT plasma for COVID‐19: A meta‐analysis of clinical trials and real‐world evidence
C Kloypan, M Saesong, J Sangsuemoon, P Chantharit, P Mongkhon |
European Journal of Clinical Investigation | 2021 |
|
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial
MB Ortigoza, H Yoon, KS Goldfeld, AB Troxel, JP Daily, Y Wu, Y Li, D Wu, GF Cobb, G Baptiste, M OKeeffe, MO Corpuz, L Ostrosky-Zeichner, A Amin, IM Zacharioudakis, DT Jayaweera, Y Wu, JV Philley, MS Devine, MS Desruisseaux, AD Santin, S Anjan, R Mathew, B Patel, M Nigo, R Upadhyay, T Kupferman, AN Dentino, R Nanchal, CA Merlo, DN Hager, K Chandran, JR Lai, J Rivera, CR Bikash, G Lasso, TP Hilbert, M Paroder, AA Asencio, M Liu, E Petkova, A Bragat, R Shaker, DD McPherson, RL Sacco, MJ Keller, CR Grudzen, JS Hochman, L Pirofski, FZ Rahman, AO Ajayi, SL Rodriguez, AG Ledesma, D Keeling, N Rappoport, SF Ebel, J Kim, M Chang, K Chan, P Patel, A Martocci, S Dave, Y Darwish, M Taveras, V Shoyelu, P Xin, E Iturrate, LC Moldolsky, BJ Raimondo, S Mendez, P Hughes, S Sterling, A S, S Yaghi, K Veloso, M Sheikh, E Visconti-Ferrara, A Fleming, H Youn, BJ Fran, R Medina, R McKell, S Khan, T Hamilton, CJ Sanchez, NH Patel, L Cleare, O Vergnolle, A Nakouzi, G Quevedo, RH Bortz, AS Wirchnianski, C Florez, R Babb, J Ayala, KZ Tsagaris, A James, I Eke, A Obeidallah, OA Sandu, S Sohval, L Serrano-Rahman, J Uehlinger, R Bartash, A Al-Abduladheem, I Gendlina, C Sheridan, A Bortnick, J Eichler, R Kaufman, S Yukelis, M Pennock, M Goggin, C Shen, J Annam, A Khokhar, D Barboto, BJ Lally, A Lee, M Lee, XA Yang, S Allen, A Malaviya, O Moussa, R Park, R Sample, A Bae, G Benoni, LL Boerger, LD Baker, MA Luther, LS Ameti, N Briggs, MR Golden, M Gormally, GS Huang, RM Johnson, AR Morrison, M Montagna-Hill, BN Rivera, GM Cortezzo, KB Debski, Nicoletti, K DeBenedictis, R Davis, C Marshall, MA Cuartas, L Beauchamps, J Bertran-Lopez, JG Zamora, M Delgado-Lelievre, S Dominguez, CC Lee, H Kusack, V Karakeshishyan, A Hajaz, D Deniz, G Garcia, K Dae, P Blenet, D Jaffe, L Olson, D Sabogal, O Blust, VD Perez, C Bornia, V Rodriguez-Perez, V Calderon, R Ramdev, A Jolly, I Guzman, R Guerra, S Brito, R Hobbs, R Denham, J Dick, MD Hernandez, LE Nielsen, SM Anjum, SC Mader, TP Stutz, M Mammadova, P Nichols, TS Khan, MR Boktour, BL Castaneda, BD Benitez, E Hinojosa, BC Guerra, A Ortiz, RS Hebbeler-Clark, PJ McShane, R Hibbard, BE Hawkins, ER Dohanich, C Wadle, KL Greenlee, J Brooks, CD Herrick, A Gode, P Bergl, K Hu, J Patel, S Srinivasan, J Graf, C Klis, K Reimer, E Carpenter, C Naczek, R Petersen, R Dex, J Drossart, J Zelten, C Brummitt, M Liang, L Yanny, G Dennison, P Runningen, B Brzezinski, S Fiebig, C Naczek, M Kasdorf, L Parameswaran, AT Corcoran, A Rohatgi, MW Wronska, X Wu, R Srinivasan, FM Deng, TD Filardo, J Pendse, SB Blaser, O Whyte, JM Gallagher, OE Thomas, D Ramos, CL Sturm-Reganato, CC Fong, IM Daus, AG Payoen, JT Chiofolo, MT Friedman, DW Wu, JL Jacobson, JG Schneider, UN Sarwar, HE Wang, RM Huebinger, G Dronavalli, Y Bai, CZ Grimes, KW Eldin, VE Umana, JG Martin, TR Heath, FO Bello, DL Ransford, M Laurent-Rolle, SV Shenoi, OB Akide-Ndunge, B Thapa, JL Peterson, K Knauf, SU Patel, LL Cheney, CA Tormey, JE Hendrickson |
JAMA internal medicine | 2021 |
|
Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19
Sarif J, Raychaudhuri D, D\u2019Rozario R, Bandopadhyay P, Singh P, Mehta P, Hoque MA, Sinha BP, Kushwaha M, Sahni S, Devi P, Chattopadhyay P, Paul SR, Ray Y, Chaudhuri K, Banerjee S, Majumdar D, Saha B, Sarkar BS, Bhattacharya P, Chatterjee S, Paul S, Ghosh P, Pandey R, Sengupta S, Ganguly D |
Frontiers in immunology | 2021 |
|
Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection
Fodor E, Müller V, Iványi Z, Berki T, Kuten Pella O, Hornyák I, Ambrus M, Sárkány Á, Skázel Á, Madár Á, Kardos D, Kemenesi G, Földes F, Nagy S, Matusovits A, János N, Tordai A, Jakab F, Lacza Z |
Infectious Diseases and Therapy | 2021 |
|
Functional Antibodies in COVID-19 Convalescent Plasma.
Herman JD, Wang C, Loos C, Yoon H, Rivera J, Dieterle ME, Haslwanter D, Jangra RK, Bortz RH 3rd, Bar KJ, Julg B, Chandran K, Lauffenburger D, Pirofski LA, Alter G |
medRxiv : the preprint server for health sciences | 2021 |
|
Convalescent Plasma Use in the United States was inversely correlated with COVID-19 Mortality: Did Plasma Hesitancy cost lives?
Casadevall A, Dragotakes Q, Johnson PW, Senefeld JW, Klassen SA, Wright RS, Joyner MJ, Paneth N, Carter RE |
2021 | |
|
Mater Artium Necessitas: The Birth of a COVID-19 Command Center
Campbell ST, Orner EP, Reyes Gil M, Fox AS, Goldstein DY, Wolgast LR, Cadoff EM, Freedman VH, Akabas MH, Prystowsky MB, Szymczak WA |
Academic Pathology | 2021 |
